Rita Machaalani1,2, Carla A Evans3, Karen A Waters3,4. 1. Department of Medicine, University of Sydney, Sydney, NSW, 2006, Australia. ritam@med.usyd.edu.au. 2. The Children's Hospital, Westmead, Sydney, NSW, 2145, Australia. ritam@med.usyd.edu.au. 3. Department of Medicine, University of Sydney, Sydney, NSW, 2006, Australia. 4. The Children's Hospital, Westmead, Sydney, NSW, 2145, Australia.
Abstract
PURPOSE: This study aimed to objectively measure adherence (compliance) and effectiveness of CPAP and BiLevel pressure support in an Australian paediatric population and determine factors associated with adherence outcomes. METHODS: Data was collected as part of routine clinical care from 2011 to 2013. Adherence was recorded by downloads from the PAP device. "Adequate" adherence was defined as ≥4 h/night for 70 % of days used. Effectiveness of therapy was measured by polysomnography (PSG) pre- and post-PAP initiation. One year follow-up was undertaken to determine the long-term utilisation of PAP therapy. RESULTS: Ninety-nine children were included (55 CPAP, 44 BiLevel). Mean age and BMI z-score were 6.9 ± 5.5 years and 0.1 ± 2.0 for CPAP and 9.8 ± 5.9 years and -0.5 ± 2.6 for BiLevel, respectively. At initial download, adequate adherence was observed in 75 % of CPAP and 91 % of BiLevel users. Mean hours of use (per night) for all nights used was 6.8 ± 2.8 and 9.3 ± 3.6 h, respectively. PSG demonstrated that CPAP use was associated with >60 % decrease in the obstructive apnoea hypopnoea index (OAHI, 19.0 ± 18.4 to 2.4 ± 3.1; p < 0.001). BiLevel use was associated with improved baseline SaO2 and TcCO2 (SaO2, 92.5 ± 5.4 % to 95.5 ± 2.9 %; p = 0.001 and reduction in TcCO2, 50.0 ± 10.9 mmHg to 44.8 ± 7.6 mmHg; p = 0.01). At follow-up, 22 (40 %) patients on CPAP and 26 (59 %) on BiLevel continued with therapy, and amongst these, adequate adherence was maintained in 76 % of CPAP and 80 % of Bilevel users. CONCLUSIONS: In this Australian paediatric cohort (predominantly non-obese), adherence with BiLevel was greater than for CPAP. Over half of our population continue to utilise PAP therapy 1 year later, and amongst these cases, adequate adherence was maintained.
PURPOSE: This study aimed to objectively measure adherence (compliance) and effectiveness of CPAP and BiLevel pressure support in an Australian paediatric population and determine factors associated with adherence outcomes. METHODS: Data was collected as part of routine clinical care from 2011 to 2013. Adherence was recorded by downloads from the PAP device. "Adequate" adherence was defined as ≥4 h/night for 70 % of days used. Effectiveness of therapy was measured by polysomnography (PSG) pre- and post-PAP initiation. One year follow-up was undertaken to determine the long-term utilisation of PAP therapy. RESULTS: Ninety-nine children were included (55 CPAP, 44 BiLevel). Mean age and BMI z-score were 6.9 ± 5.5 years and 0.1 ± 2.0 for CPAP and 9.8 ± 5.9 years and -0.5 ± 2.6 for BiLevel, respectively. At initial download, adequate adherence was observed in 75 % of CPAP and 91 % of BiLevel users. Mean hours of use (per night) for all nights used was 6.8 ± 2.8 and 9.3 ± 3.6 h, respectively. PSG demonstrated that CPAP use was associated with >60 % decrease in the obstructive apnoea hypopnoea index (OAHI, 19.0 ± 18.4 to 2.4 ± 3.1; p < 0.001). BiLevel use was associated with improved baseline SaO2 and TcCO2 (SaO2, 92.5 ± 5.4 % to 95.5 ± 2.9 %; p = 0.001 and reduction in TcCO2, 50.0 ± 10.9 mmHg to 44.8 ± 7.6 mmHg; p = 0.01). At follow-up, 22 (40 %) patients on CPAP and 26 (59 %) on BiLevel continued with therapy, and amongst these, adequate adherence was maintained in 76 % of CPAP and 80 % of Bilevel users. CONCLUSIONS: In this Australian paediatric cohort (predominantly non-obese), adherence with BiLevel was greater than for CPAP. Over half of our population continue to utilise PAP therapy 1 year later, and amongst these cases, adequate adherence was maintained.
Entities:
Keywords:
Bilevel; CPAP; Compliance; NIV; Non-invasive ventilation; OSA
Authors: Amy M Sawyer; Nalaka S Gooneratne; Carole L Marcus; Dafna Ofer; Kathy C Richards; Terri E Weaver Journal: Sleep Med Rev Date: 2011-06-08 Impact factor: 11.609
Authors: A Castorena-Maldonado; L Torre-Bouscoulet; S Meza-Vargas; J C Vázquez-García; E López-Escárcega; R Pérez-Padilla Journal: Int J Pediatr Otorhinolaryngol Date: 2008-10-04 Impact factor: 1.675
Authors: Clete A Kushida; Alejandro Chediak; Richard B Berry; Lee K Brown; David Gozal; Conrad Iber; Sairam Parthasarathy; Stuart F Quan; James A Rowley Journal: J Clin Sleep Med Date: 2008-04-15 Impact factor: 4.062
Authors: Eun Kyeong Kang; Melissa S Xanthopoulos; Ji Young Kim; Casandra Arevalo; Justine Shults; Suzanne E Beck; Carole L Marcus; Ignacio E Tapia Journal: J Clin Sleep Med Date: 2019-06-15 Impact factor: 4.062
Authors: Sherri L Katz; Valerie G Kirk; Joanna E MacLean; Glenda N Bendiak; Mary-Ann Harrison; Nicholas Barrowman; Lynda Hoey; Linda Horwood; Stasia Hadjiyannakis; Laurent Legault; Bethany J Foster; Evelyn Constantin Journal: J Clin Sleep Med Date: 2020-02-07 Impact factor: 4.062
Authors: Miriam R Weiss; Michelle L Allen; Jeremy S Landeo-Gutierrez; Jenny P Lew; Julia K Aziz; Sylvan S Mintz; Claire M Lawlor; Benjamin J Becerra; Diego A Preciado; Gustavo Nino Journal: J Clin Sleep Med Date: 2021-05-01 Impact factor: 4.062
Authors: Prabhjot K Bedi; Maria Luisa Castro-Codesal; Robin Featherstone; Mohammed M AlBalawi; Bashar Alkhaledi; Anita L Kozyrskyj; Carlos Flores-Mir; Joanna E MacLean Journal: Front Pediatr Date: 2018-02-12 Impact factor: 3.418